Dissemin is shutting down on January 1st, 2025

Published in

Humana Press, Clinical Reviews in Allergy and Immunology, 3(60), p. 348-356, 2021

DOI: 10.1007/s12016-021-08837-6

Links

Tools

Export citation

Search in Google Scholar

Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema

Journal article published in 2021 by Steven de Maat ORCID, Kusumam Joseph ORCID, Coen Maas ORCID, Allen P. Kaplan ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractThe plasma contact system is the initiator of the intrinsic pathway of coagulation and the main producer of the inflammatory peptide bradykinin. When plasma is exposed to a negatively charged surface the two enzymes factor XII (FXII) and plasma prekallikrein (PK) bind to the surface alongside the co-factor high molecular weight kininogen (HK), where PK is non-covalently bound to. Here, FXII and PK undergo a reciprocal activation feedback loop that leads to full contact system activity in a matter of seconds. Although naturally occurring negatively charged surfaces have shown to be involved in the role of the contact system in thrombosis, such surfaces are elusive in the pathogenesis of bradykinin-driven hereditary angioedema (HAE). In this review, we will explore the molecular mechanisms behind contact system activation, their assembly on the endothelial surface, and their role in the HAE pathophysiology.